Drug intelligence / Profile preview

Corryocactus brevistylus methanol extract

Development stage: Preclinical
Lead developer: National Agrarian University La Molina
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules

Overview

Corryocactus brevistylus methanol extract is a botanical extract prepared from the freeze-dried fruit pulp of *Corryocactus brevistylus* (commonly known as Sanky), a Peruvian cactus native to the Andean regions. The extract has been investigated in vitro for its antibacterial properties, demonstrating dose-dependent inhibitory activity against Gram-positive pathogens such as *Staphylococcus aureus* and *Enterococcus faecalis*. It is being studied as a potential natural antimicrobial agent.

Other names: Corryocactus brevistylus fruit methanol extractSanky fruit methanol extractSanky methanol extract

Beyond the preview

Go deeper on Corryocactus brevistylus methanol extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corryocactus brevistylus methanol extract.